.svg)
average weight loss with glp-1 agonists In Obesity Women using GLP-1 receptor agonists
Description
we reported the characteristics of the included trials in Table 1, and the excluded studies in Table S2
2020;3(10):e2020969
These two peptides (GLP-1 and GIP) potentiate glucose-stimulated insulin secretion in an additive manner, likely contribute equally to the incretin effect and together can fully account for the majority of the incretin effect in humans
Alter, M
Health effects of overweight and obesity in 195 countries over 25 years
doi: 10.1111/all.14879 101 HurJKangJYKimYKLeeSYLeeHY
